Analystreport

Globus Medical, Inc. (NYSE: GMED) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $80.00 to $75.00.

Globus Medical, Inc. Class A  (GMED) 
Last globus medical, inc. class a earnings: 2/20 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.globusmedical.com